Table 4 Individuals with any or specific neurodegenerative disease (exposed), compared to individuals without such a condition (unexposed) - an analysis among all participants with a positive test result for COVID-19
| Â | No.(%) of cases | Odds Ratioa | |
|---|---|---|---|
Exposed | Unexposed | ||
COVID-19 related death | |||
 Any neurodegenerative disease | 195/718 (27.2) | 986/17220 (5.7) | 2.08 (1.71, 2.53) |
  Primary neurodegenerative diseases | 132/512 (25.8) | 1049/17426 (6.0) | 1.91 (1.52, 2.40) |
  Vascular neurodegenerative diseases | 47/143 (32.9) | 1134/17795 (6.4) | 1.89 (1.29, 2.77) |
  Other neurodegenerative diseases | 98/322 (30.4) | 1083/17616 (6.1) | 2.16 (1.65, 2.82) |
 Selected specific neurodegenerative diseases | |||
  Alzheimer’s disease | 54/220 (24.5) | 1127/17718 (6.4) | 1.58 (1.12, 2.21) |
  Parkinson’s disease | 52/196 (26.5) | 1129/17742 (6.4) | 1.97 (1.39, 2.78) |